CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
91.60
0.97%
Market Trading Hours* (UTC) Opens on Monday at 07:00

Mon - Fri: 07:00 - 15:20

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.40
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.015699 %
Charges from full value of position ($-2.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.015699%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.006523 %
Charges from full value of position ($-1.24)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.006523%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency CHF
Margin 5%
Stock exchange Switzerland
Commission on trade 0%

*Information provided by Capital.com

Novartis AG ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 92.5
Open* 91.85
1-Year Change* 21.66%
Day's Range* 91.55 - 92.15
52 wk Range 73.32-93.95
Average Volume (10 days) 2.27M
Average Volume (3 months) 55.31M
Market Cap 202.26B
P/E Ratio 27.73
Shares Outstanding 2.07B
Revenue 47.30B
EPS 3.20
Dividend (Yield %) 3.61052
Beta 0.96
Next Earnings Date Oct 24, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 22, 2023 91.60 0.00 0.00% 91.60 92.20 91.25
Sep 21, 2023 92.50 -0.20 -0.22% 92.70 93.80 92.10
Sep 20, 2023 92.75 0.20 0.22% 92.55 93.20 91.95
Sep 19, 2023 91.60 0.65 0.71% 90.95 92.15 90.45
Sep 18, 2023 91.70 0.05 0.05% 91.65 92.40 91.25
Sep 15, 2023 92.05 0.55 0.60% 91.50 92.75 90.65
Sep 14, 2023 90.15 0.35 0.39% 89.80 91.10 89.65
Sep 13, 2023 89.15 -0.15 -0.17% 89.30 89.95 88.40
Sep 12, 2023 88.95 0.85 0.96% 88.10 90.05 88.10
Sep 11, 2023 88.20 0.55 0.63% 87.65 88.45 87.35
Sep 8, 2023 87.95 0.10 0.11% 87.85 88.30 87.35
Sep 7, 2023 88.25 1.60 1.85% 86.65 88.40 86.65
Sep 6, 2023 87.00 -0.05 -0.06% 87.05 87.05 85.85
Sep 5, 2023 87.75 -0.65 -0.74% 88.40 88.90 87.25
Sep 4, 2023 88.80 -0.25 -0.28% 89.05 89.60 88.20
Sep 1, 2023 89.10 0.15 0.17% 88.95 89.35 88.40
Aug 31, 2023 87.85 -1.80 -2.01% 89.65 89.75 87.85
Aug 30, 2023 89.90 -0.55 -0.61% 90.45 90.45 89.60
Aug 29, 2023 90.20 -0.25 -0.28% 90.45 90.75 89.50
Aug 28, 2023 90.35 0.75 0.84% 89.60 91.15 89.60

Novartis - CHF Events

Time (UTC) Country Event
Tuesday, October 24, 2023

Time (UTC)

06:30

Country

CH

Event

Q3 2023 Novartis AG Earnings Release
Q3 2023 Novartis AG Earnings Release

Forecast

-

Previous

-
Monday, November 13, 2023

Time (UTC)

10:59

Country

CH

Event

Novartis AG Impact & Sustainability Annual Event
Novartis AG Impact & Sustainability Annual Event

Forecast

-

Previous

-
Wednesday, November 15, 2023

Time (UTC)

10:59

Country

CH

Event

Novartis AG at UBS European Conference
Novartis AG at UBS European Conference

Forecast

-

Previous

-

Time (UTC)

10:59

Country

CH

Event

Novartis AG at Wolfe Research Healthcare Conference
Novartis AG at Wolfe Research Healthcare Conference

Forecast

-

Previous

-
Tuesday, November 28, 2023

Time (UTC)

10:59

Country

CH

Event

Novartis AG R&D Day
Novartis AG R&D Day

Forecast

-

Previous

-
Wednesday, March 6, 2024

Time (UTC)

09:00

Country

CH

Event

Novartis AG Annual Shareholders Meeting
Novartis AG Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 51742 52877 49898 48624 46017
Revenue 51742 52877 49898 48624 46017
Cost of Revenue, Total 14998 15435 14400 13930 13555
Gross Profit 36744 37442 35498 34694 32462
Total Operating Expense 42545 41188 39746 39538 31824
Selling/General/Admin. Expenses, Total 14190 14815 14093 14319 13690
Research & Development 9088 9041 8484 8386 8154
Depreciation / Amortization 158 109 64 50 179
Unusual Expense (Income) 3402 1173 2503 2284 -4309
Other Operating Expenses, Total 449 653 538 607 549
Operating Income 9197 11689 10152 9086 14193
Interest Income (Expense), Net Non-Operating -543 14628 -146 -36 -5
Other, Net -283 -180 -128 -110 -93
Net Income Before Taxes 8371 26137 9878 8940 14095
Net Income After Taxes 6955 24018 8071 7147 12800
Minority Interest 0 3 1 -5 -3
Net Income Before Extra. Items 6955 24021 8072 7142 12797
Net Income 6955 24021 8072 11732 12611
Income Available to Common Excl. Extra. Items 6955 24021 8072 7142 12797
Income Available to Common Incl. Extra. Items 6955 24021 8072 11732 12611
Dilution Adjustment
Diluted Net Income 6955 24021 8072 11732 12611
Diluted Weighted Average Shares 2197 2260 2296 2319 2344
Diluted EPS Excluding Extraordinary Items 3.16568 10.6288 3.51568 3.07978 5.45947
Dividends per Share - Common Stock Primary Issue 3.46171 3.19907 3.38945 3.04815 2.90402
Diluted Normalized EPS 4.47075 11.1183 4.40641 3.86715 3.79006
Total Extraordinary Items 4590 -186
Interest Expense (Income) - Net Operating 260 -38 -336 -38 6
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 13936 13208 13001 12842 13085
Revenue 13936 13208 13001 12842 13085
Cost of Revenue, Total 4006 3829 3837 3657 3749
Gross Profit 9930 9379 9164 9185 9336
Total Operating Expense 11016 10352 11052 10674 10857
Selling/General/Admin. Expenses, Total 3673 3401 3699 3404 3589
Research & Development 2349 2272 2318 2263 2251
Depreciation / Amortization 45 153 42 42 39
Interest Expense (Income) - Net Operating 29 46 -28 90 96
Unusual Expense (Income) 858 298 1145 1068 996
Other Operating Expenses, Total 56 353 39 150 137
Operating Income 2920 2856 1949 2168 2228
Interest Income (Expense), Net Non-Operating -226 -212 -222 -219 -202
Other, Net 75 96 14 -30 16
Net Income Before Taxes 2769 2740 1741 1919 2042
Net Income After Taxes 2317 2294 1466 1575 1695
Minority Interest -1 -1 0 -2 -1
Net Income Before Extra. Items 2316 2293 1466 1573 1694
Net Income 2316 2293 1466 1573 1694
Income Available to Common Excl. Extra. Items 2316 2293 1466 1573 1694
Income Available to Common Incl. Extra. Items 2316 2293 1466 1573 1694
Diluted Net Income 2316 2293 1466 1573 1694
Diluted Weighted Average Shares 2095 2120 2158 2180 2211
Diluted EPS Excluding Extraordinary Items 1.10549 1.0816 0.67933 0.72156 0.76617
Dividends per Share - Common Stock Primary Issue 0 0 3.46171 0 0
Diluted Normalized EPS 1.45098 1.20956 1.14055 1.12553 1.14122
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 36910 45718 29673 29504 35563
Cash and Short Term Investments 18726 28113 11293 11234 15718
Cash 2877 3396 3750 3247 3121
Cash & Equivalents 4640 9011 5908 7865 10150
Short Term Investments 11209 15706 1635 122 2447
Total Receivables, Net 9894 9621 10036 10337 11036
Accounts Receivable - Trade, Net 8066 8005 8217 8301 8739
Total Inventory 7175 6666 7131 5982 6956
Prepaid Expenses 911 1102 943 898 812
Other Current Assets, Total 204 216 270 1053 1041
Total Assets 117453 131795 127778 118370 145563
Property/Plant/Equipment, Total - Net 12195 13106 13939 13746 15696
Property/Plant/Equipment, Total - Gross 26304 28708 29894 28676 34028
Accumulated Depreciation, Total -14109 -15602 -15955 -14930 -18332
Goodwill, Net 29301 29595 29999 26524 35294
Intangibles, Net 31644 34182 36809 28787 38719
Long Term Investments 1606 2268 11611 10538 9789
Note Receivable - Long Term 948 973 922 624 908
Other Long Term Assets, Total 4849 5953 4825 8647 9594
Total Current Liabilities 28656 30208 33059 28264 29607
Accounts Payable 5146 5553 5403 5424 5556
Accrued Expenses 5334 5100 5336 5058 5105
Notes Payable/Short Term Debt 3635 3606 7319 4844 6430
Current Port. of LT Debt/Capital Leases 2492 2896 2558 2248 3190
Other Current Liabilities, Total 12049 13053 12443 10690 9326
Total Liabilities 58111 64140 71180 62896 66949
Total Long Term Debt 21782 24523 27978 22056 22470
Long Term Debt 20244 22902 26259 20353 22470
Deferred Income Tax 2686 3070 3141 5867 7475
Minority Interest 81 167 68 77 78
Other Liabilities, Total 4906 6172 6934 6632 7319
Total Equity 59342 67655 56598 55474 78614
Common Stock 890 901 913 936 944
Retained Earnings (Accumulated Deficit) 63540 70989 57157 59274 82191
Treasury Stock - Common -92 -48 -53 -80 -69
Unrealized Gain (Loss) -198 206
Other Equity, Total -4798 -4187 -1419 -4656 -4658
Total Liabilities & Shareholders’ Equity 117453 131795 127778 118370 145563
Total Common Shares Outstanding 2119.61 2234.94 2256.82 2265.01 2311.17
Capital Lease Obligations 1538 1621 1719 1703
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total Current Assets 32114 36910 36954 38142 37236
Cash and Short Term Investments 12260 18930 19103 19758 18814
Cash & Equivalents 12000 7517 8726 3625 13852
Short Term Investments 260 11413 10377 16133 4962
Total Receivables, Net 9183 8334 8680 8910 8678
Accounts Receivable - Trade, Net 8916 8066 8422 8643 8409
Total Inventory 7886 7175 6779 6880 6997
Other Current Assets, Total 2785 2471 2392 2594 2747
Total Assets 112241 117453 118464 122910 125218
Property/Plant/Equipment, Total - Net 12348 12195 11731 12206 12861
Goodwill, Net 29481 29301 28668 29113 29636
Intangibles, Net 30451 31644 31888 33367 34853
Long Term Investments 2555 2554 2491 2580 2906
Other Long Term Assets, Total 5292 4849 6732 7502 7726
Total Current Liabilities 30549 28656 28160 27646 29807
Accounts Payable 5426 5146 4693 4969 5083
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 7166 6127 7204 7247 6902
Other Current Liabilities, Total 17957 17383 16263 15430 17822
Total Liabilities 60182 58111 57644 59985 63678
Total Long Term Debt 21985 21782 21235 23784 24373
Long Term Debt 20396 20244 19732 22232 22796
Capital Lease Obligations 1589 1538 1503 1552 1577
Deferred Income Tax 2727 2686 2719 3122 3384
Minority Interest 83 81 78 81 164
Other Liabilities, Total 4838 4906 5452 5352 5950
Total Equity 52059 59342 60820 62925 61540
Common Stock 842 890 890 890 901
Retained Earnings (Accumulated Deficit) 51253 58544 60000 62095 60699
Treasury Stock - Common -36 -92 -70 -60 -60
Total Liabilities & Shareholders’ Equity 112241 117453 118464 122910 125218
Total Common Shares Outstanding 2097.4 2119.61 2150.98 2182.79 2212.58
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 6955 24018 8071 7147 12800
Cash From Operating Activities 14236 15071 13650 13625 14272
Cash From Operating Activities 1873 1807 2088 1852 1783
Amortization 5308 4306 4376 3974 3428
Non-Cash Items 4404 -11714 3842 3369 -2315
Cash Taxes Paid 1975 2342 1833 1876 1506
Cash Interest Paid 696 664 703 793 816
Changes in Working Capital -4304 -3346 -4727 -2717 -1424
Cash From Investing Activities 1468 4208 -13182 -2226 -5591
Capital Expenditures -2671 -2971 -2585 -2257 -2648
Other Investing Cash Flow Items, Total 4139 7179 -10597 31 -2943
Cash From Financing Activities -20562 -16264 -2208 -13627 -4244
Financing Cash Flow Items 55 94 -199 3307 -119
Total Cash Dividends Paid -7506 -7368 -6987 -6645 -6966
Issuance (Retirement) of Stock, Net -10552 -3004 -2094 -5332 -1336
Issuance (Retirement) of Debt, Net -2559 -5986 7072 -4957 4177
Foreign Exchange Effects -32 -266 286 69 -26
Net Change in Cash -4890 2749 -1454 -2159 4411
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 2294 6955 5489 3914 2219
Cash From Operating Activities 2957 14236 10125 5404 1649
Cash From Operating Activities 377 7181 5233 3207 1405
Amortization 1619
Non-Cash Items 1085 4404 3417 2164 918
Cash Taxes Paid 348 1975 1559 1239 633
Cash Interest Paid 123 696 475 308 110
Changes in Working Capital -2418 -4304 -4014 -3881 -2893
Cash From Investing Activities 10621 1468 2935 -2263 9365
Capital Expenditures -470 -2671 -2024 -1442 -859
Other Investing Cash Flow Items, Total 11091 4139 4959 -821 10224
Cash From Financing Activities -9202 -20562 -16568 -11830 -9528
Financing Cash Flow Items -169 55 99 97 22
Total Cash Dividends Paid -7255 -7506 -7506 -7506 -7506
Issuance (Retirement) of Stock, Net -2727 -10552 -7874 -5156 -2448
Issuance (Retirement) of Debt, Net 949 -2559 -1287 735 404
Foreign Exchange Effects 107 -32 -173 -93 -41
Net Change in Cash 4483 -4890 -3681 -8782 1445
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
BlackRock Institutional Trust Company, N.A. Investment Advisor 5.3489 121820582 0 2022-12-31 LOW
Sandoz Family Other Insider Investor 3.9138 89135960 0 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.7121 61766714 296752 2023-07-31 LOW
UBS Asset Management (Switzerland) Investment Advisor 2.4548 55906821 176139 2022-12-31 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 2.3806 54217976 0 2022-12-31 LOW
Credit Suisse Asset Management Investment Advisor/Hedge Fund 2.1663 49335879 -677105 2022-12-31 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 1.9274 43897216 21743 2023-07-31 LOW
Zürcher Kantonalbank (Asset Management) Bank and Trust 1.1612 26446726 118560 2023-07-31 LOW
BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.8719 19856757 66327 2023-07-31 LOW
Artisan Partners Limited Partnership Investment Advisor 0.7614 17341049 362533 2023-06-30 LOW
Dodge & Cox Investment Advisor/Hedge Fund 0.7467 17006670 -3098900 2023-06-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5902 13441576 3568 2023-07-31 LOW
Capital Research Global Investors Investment Advisor 0.5743 13079359 -7484 2023-06-30 LOW
DWS Investment GmbH Investment Advisor/Hedge Fund 0.5467 12450739 284839 2023-07-31 LOW
Pictet Asset Management Ltd. Investment Advisor/Hedge Fund 0.5323 12122921 37703 2023-04-30 LOW
California Public Employees' Retirement System Pension Fund 0.5222 11892523 2527466 2022-06-30 LOW
Nuveen LLC Pension Fund 0.3751 8543005 47653 2023-07-31 LOW
MFS Investment Management Investment Advisor/Hedge Fund 0.3554 8095235 -17005 2023-06-30 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.3527 8032113 3765 2023-05-31 LOW
Amundi Asset Management, SAS Investment Advisor/Hedge Fund 0.2998 6828283 -276205 2023-07-31 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Novartis - CHF Company profile

Novartis AG (NVS) is a global pharmaceutical company.  Founded in 1996 through a merger of Ciba-Geigy and Sandoz, Novartis is headquartered in Basel, Switzerland. The firm has two divisions: Innovative Medicines and Sandoz.

Innovative Medicines offer prescription medicines and create treatments in areas of respiratory, ophthalmology, neuroscience, immunology, hepatology, dermatology, cardiovascular, renal and metabolism. 

Sandoz develops, manufactures and markets generic pharmaceuticals and biosimilars. Sandoz products include: Adakveo (crizanlizumab), Afinitor Disperz/Votubia (everolimus) and Arzerra (ofatumumab) for Oncology; and Aimovig (erenumab) for neuroscience. 

In 2020, in response to the pandemic, the company collaborated with Molecular Partners to develop ensovibep, a DARPin therapeutic candidate designed for potential use against Covid-19. 

The company’s shares have been listed on the New York Stock Exchange (NYSE) since 2000. Novartis AG stock is traded under the ticker symbol NVS. You can track live NVS share value and price history at Capital.com.

Industry: Pharmaceuticals (NEC)

Lichtstrasse 35
BASEL
BASEL-STADT 4056
CH

Income Statement

  • Annual
  • Quarterly

News

EUR/USD tests key support

EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

14:32, 21 September 2023
Bank of England building

BoE leaves rates unchanged, GBP drops further as investors look for more clarity

The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

11:45, 21 September 2023
British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

GBP softer after CPI surprise, JPY focused on any further hints from Ueda

GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

12:42, 20 September 2023

How to Trade The Break & Retest

In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

11:59, 20 September 2023

Cable coils near lows ahead of Fed and BoE rate decisions

It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.

14:16, 19 September 2023

FTSE 100 Technical Outlook - 18 September 2023

In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.

06:55, 19 September 2023
View of the City of London’s illuminated financial district skyline at dusk

Market Analysis: FTSE 100 boosted by ECB rate hike end and iron ore rally

The FTSE 100 rose over 2% on Thursday as the ECB announced no more rate hikes for now.

13:46, 15 September 2023

People also watch

XRP/USD

0.51 Price
-0.240% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01192

BTC/USD

26,617.40 Price
-0.080% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 85.00

Oil - Crude

90.14 Price
+0.770% 1D Chg, %
Long position overnight fee 0.0415%
Short position overnight fee -0.0634%
Overnight fee time 21:00 (UTC)
Spread 0.030

ETH/USD

1,595.12 Price
-0.070% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 5.40

Still looking for a broker you can trust?

Join the 555.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading